Tytuł pozycji:
Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial
-
Tytuł:
-
Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial
-
Autorzy:
-
Venter, Willem D F
Moorhouse, Michelle
Sokhela, Simiso
Serenata, Celicia
Akpomiemie, Godspower
Qavi, Ambar
Mashabane, Nonkululeko
Arulappan, Natasha
Sim, Joel W
Sinxadi, Phumla Z
Wiesner, Lubbe
Maharaj, Ellisha
Wallis, Carole
Boyles, Tom
Ripin, David
Stacey, Sarah
Chitauri, Gila
Hill, Andrew
-
Źródło:
-
In The Lancet HIV July 2019 6(7):e428-e437
-
